Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 26, 2020 08:01 ET | Source: Seelos Therapeutics, Inc.

Seelos Therapeutics Announces Additional Interim Data from Phase I Studies of Intranasal Racemic Ketamine (SLS-002)

NEW YORK, Feb. 26, 2020 (GLOBE NEWSWIRE) -- Seelos Therapeutics, Inc. (Nasdaq: SEEL), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system...
October 21, 2019 09:00 ET | Source: Seelos Therapeutics, Inc.

Seelos Therapeutics Announces Amendment of SLS-002 Agreement

Seelos Plans to Study SLS-002 Initially in Suicidality in Major Depressive Disorder NEW YORK, Oct. 21, 2019 (GLOBE NEWSWIRE) -- Seelos Therapeutics, Inc. (Nasdaq: SEEL), a clinical-stage...
August 01, 2019 09:00 ET | Source: Seelos Therapeutics, Inc.

Seelos Therapeutics Reports Q2 2019 Pipeline Update

NEW YORK, Aug. 01, 2019 (GLOBE NEWSWIRE) -- Seelos Therapeutics, Inc. (NASDAQ: SEEL), a clinical-stage biopharmaceutical company, today released its second quarter pipeline update. “We have made...
October 09, 2013 15:02 ET | Source: Medical World Americas

Momentum for MEDICAL WORLD AMERICAS continues to grow

HOUSTON, TEXAS, Oct. 9, 2013 (GLOBE NEWSWIRE) -- MEDICAL WORLD AMERICAS has begun to reveal its extensive list of distinguished speakers for its 2014 conference, while also boasting rapid sales for...